In summary, the current work supports the role of S100A4 in pancreatic cancer progression in vivo, and provides novel insights into the signaling mechanisms by which S100A4 promotes tumorigenic capacity of pancreatic carcinoma cells. This evidence concerns the gene S100A4 and familial pancreatic carcinoma.